U.S. Reviewing if Moderna Shot Tied to Higher Heart Inflammation Risk in Young Adults

Publisher's Picks
608

Translate to Spanish or other 102 languages!

Image for illustration only

By Celine Castronuovo – The Hill

- Advertisement -

Federal health officials are conducting an investigation into the effects of the Moderna COVID-19 vaccine following new research that showed it may be linked to a higher risk of heart inflammation in young adults than previously though, according to a report from The Washington Post.

Two people familiar with the review told the Post that the heart condition, called myocarditis, is likely still extremely rare, but added that the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) are looking into new Canadian data suggesting a greater risk among a specific demographic that have received the Moderna vaccine. Read more, click here.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Texas says schools now must notify families of positive COVID-19 cases in classrooms
Next article
FDA Approves First COVID-19 Vaccine

More Articles

New Medical Technology at STHS Heart Targets Difficult-to-Control High Blood Pressure

A new procedure offers long-term relief for patients struggling with severe high blood pressure that resists traditional drugs.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Neuroscience Institute Nationally Recognized for Commitment to Excellence in Stroke Care

DHR Health Neuroscience Institute received the American Heart Association’s Get With The Guidelines® - Stroke Gold Plus quality achievement award for its commitment to ensuring people experiencing a stroke receive timely, appropriate treatment based on nationally recognized, research-based guidelines, ultimately helping to save lives and reduce disability.

Accelerator Returns October 15, Expanding Its Focus on Al, Healthcare Access and Community Impact

AltaCair Foundation, in partnership with Genentech as the 2026 co-host, will host its fourth annual Accelerator summit on Thursday, October 15, 2026, from 8:00 a.m. to 12:00 p.m. at the Harlingen Convention Center.
- Advertisement -